OMEROS CORP Share Price
OMEROS CORP (OMER) had Share Price of $9.51 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2026-08-12
- 2026-06-30: Share Price $9.51.
- 2026-03-31: Share Price $10.56.
- 2025-12-31: Share Price $17.18.
- 2025-09-30: Share Price $4.10.
| Period end | Share Price |
|---|---|
| 2026-06-30 | $9.51 10-Q · filed 2026-08-12 |
| 2026-03-31 | $10.56 10-Q · filed 2026-05-13 |
| 2025-12-31 | $17.18 10-K · filed 2026-03-31 |
| 2025-09-30 | $4.10 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $8.22 10-Q · filed 2025-05-15 |
| 2024-12-31 | $9.88 10-K · filed 2025-03-31 |
| 2024-09-30 | $3.97 10-Q · filed 2024-11-13 |
| 2024-06-28 | $4.06 10-Q · filed 2024-08-07 |
| 2024-03-31 | $3.45 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.27 10-K · filed 2024-04-01 |
| 2023-09-30 | $2.92 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.44 10-Q · filed 2023-08-09 |
| 2020-08-31 | $14.50 10-K · filed 2023-03-13 |
| 2020-08-14 | $14.50 10-Q · filed 2021-11-09 |
| 2019-12-31 | $13.10 10-K · filed 2022-03-01 |
| 2017-08-31 | $22.75 10-K · filed 2020-03-02 |
| 2016-08-31 | $11.50 10-K · filed 2019-03-01 |
| 2015-02-28 | $20.03 10-K · filed 2018-03-01 |
| 2014-09-30 | $11.50 10-Q · filed 2014-11-10 |
| 2014-06-30 | $11.50 10-Q · filed 2014-08-11 |
| 2014-03-31 | $11.50 10-K · filed 2017-03-16 |
| 2013-05-31 | $4.14 10-K · filed 2016-03-15 |
| 2013-05-09 | $4.14 10-K · filed 2014-03-13 |
| 2012-07-31 | $10.25 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |